You have no items in your cart.
First Patient Dosed in Phase 3 Trial Testing Melflufen Triple Combo
The first participant has been dosed in a Phase 3 trial investigating a triple combination ...
More from COVID-19 News and Columns
-
-
CAD in COVID-19 Patients May Lead to Blood Typing Abnormalities
COVID-19 can be associated with the development of cold agglutinin disease (CAD), leading to the ... -
Online for 2021, Team Cure SMA Race Series Planning Variety of Events
The COVID-19 pandemic has forced many activities to be online only, but in the case ... -
New Technique May Help Isolate, Characterize T-cells in MS Research
Scientists at the UCLA Broad Stem Cell Research Center have developed a technique able to ... -
This Is ‘Soaring With Hope’ — Welcome Aboard!
Doesn’t it feel like we all carry a lot of baggage in life? If we ... -
Remembering Keith Andrus, Who Left His Mark on the FA Community
Sticking to a New Year’s resolution may better our lives in the short-term, but thinking ... -
Each PH Journey Is Unique, and It’s Not a Competition
Online support groups for rare diseases like pulmonary hypertension (PH) are essential spaces that offer ... -
No Matter Your Hardships, Today Is a Great Day to Be Alive
I’ve lost two moms in my lifetime. My biological mom, Debbie, who was with me ... -
Transplant in the Time of Coronavirus
On a beautiful Thursday afternoon late last May, my partner and I took the dogs ... -
ASF’s 15q Clinical Research Network Offers Q & A on COVID-19 Vaccines
As COVID-19 vaccination programs are being rolled out across the U.S., the Angelman Syndrome Foundation’s 15q ... -
Weighing the Risks and Benefits of COVID-19 Vaccines
I never liked group projects in school. Whenever one was announced, I’d groan and silently ... -
I Make Sure My Support System Is Strong
When I’m deep in thought, reflecting on my life, I shudder to think who and ... -
Finding a Silver Lining in the Wake of 2020 and the Pandemic
It’s obvious that things don’t change simply because we turn the page on another calendar ... -
Oral IMR-687 Seen to Lessen VOCs, Pain Crises in Patients in Phase 2a Trial
Six months of treatment with oral IMR-687 safely and effectively reduced the number of vaso-occlusive crises ... -
First Patient Enrolls in Study of NAC for Targeted Treatment in IPF
The first patient has enrolled in a Phase 3 clinical trial testing whether N-acetyl cysteine ...